Xconomy’s Digital Events →
NKT Therapeutics is developing drugs that target a class of immune cells known as natural killer T cells.
Sponsored · Whitepaper
A Guide to Performing Check-ups on Pharmaceutical Distribution & Patient Access Programs
Acknowledging various stakeholder networks and regulatory environment variances is essential to uncover the right decision-makers in support of biologics or biosimilars
Explore the different sources of funding, their relative merits, and how you should best utilize that funding at each stage of your research